DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Stifel Nicolaus Initiates Coverage On Precision BioSciences with Buy Rating, Announces $21 Price Target

Stifel Nicolaus analyst Benjamin Burnett initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and a $21 price target.

Benzinga · 03/05/2020 09:50

Stifel Nicolaus analyst Benjamin Burnett initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and a $21 price target.